乳腺钼靶片计算机光密度测定的临床应用研究

目的：利用计算机对乳腺钼靶片上病灶中心及病灶周围影像光密度的测定，来探索良、恶性乳腺病变之间以及各种病变病灶中心与病灶周围影像的密度差异：探讨病理基础和临床意义。材料和方法：随机选取１００例临床可扪及乳腺＂肿块＂的女性病人，进行乳腺钼靶Ｘ线检查，将检出病变的１０２张钼靶片进行计算机处理后，对病灶中心及病灶周围组织影像的光密度进行测定。所有病例除炎性病变外均取得病理结果。结果：１．良性病变的病灶中心密度与病灶周围密度无显著差异（Ｐ＞０．５），良性肿块（指纤维腺瘤和囊肿）的病灶中心与病灶周围密度间仅提示一种可能存在显著差异的趋势（０．１＞Ｐ＞０．０５）；２．乳腺癌病灶中心与病灶周围密度之间存在非常显著的差异（Ｐ＜０．００１）；３．良、恶性肿瘤病灶中心密度之间存在较显著差异（Ｐ＜０．０５）。结论：本研究的结果有助于乳腺良、恶性病变的鉴别诊断和提高早期乳腺癌的检出率。     

Correlation of Age and HRT Use with Breast Density as Assessed by Quantra™

Breast density is a significant predictor in the risk of developing breast cancer. Several methods are available for assessing breast density, but most are subject to intra‐observer variability and are unable to assess the breast as a three‐dimensional structure. Using Quantra^? to quantify breast density, we have correlated this with risk factors to determine what impact these variables have on breast density. Women attending for full field digital mammography at the South West London Breast Screening Unit between December 2008 and March 2009 were invited to participate in the study by questionnaire. Consenting women returned the questionnaire allowing further data collection including demographics, menopausal status and hormone replacement therapy (HRT) use. Data were correlated against breast density measurements to determine the degree of association. Mammograms were assessed on a Hologic^? workstation and breast density calculated using Quantra^?. Quantra^? is an automated algorithm for volumetric assessment of breast tissue composition from digital mammograms. Six‐hundred and eighty‐three women were invited to participate. Those with implants or mastectomy were excluded. Three‐hundred and twenty questionnaires were fully completed and able to be assessed. The mean age of participants was 59 years (range 49–81). Mean density was 19.7% (range 8.5–48.5%). There was a decrease in density with age (Pearson product‐moment correlation coefficient ?0.17). Correlation between density and HRT use showed a significant positive result (correlation coefficient 0.07). Quantra^? has shown to be an accurate, reproducible tool for quantifying breast density, demonstrated by its correlation with lifestyle and demographic data. Given its ease of acquisition this may be the future of breast density quantification in the digital age.     

The Breast Radiologist as a Public Educator: Designing an Effective Presentation for a Lay Audience

Educating the public about breast cancer screening and diagnosis is important. Medical and regulatory agencies encourage shared decision making about undergoing breast cancer screening, and there are many places women can get information and misinformation. The Internet and other media sources present information that may not be correct or understandable. Breast radiologists are uniquely qualified to provide women with the accurate information necessary to enable informed choices. As a specialty, we have an obligation to our community to provide relevant and understandable information. We can accomplish that through community outreach forums. Presentations should be understandable with plain language, focusing on our key message and using pertinent images or icons. Slides should be simple and avoid medical jargon or complex statistics. As we engage with the community, we provide a vital service to the health of our community and foster respect of our specialty.     

Improving Patient Comprehension of Screening Mammography Recall Lay Letters

PurposeIn accordance with the Mammography Quality Standards Act, recall lay letters should be written using language that is “easily understood by a lay person.” The authors hypothesized that the readability of their institution’s current recall lay letter may contribute to the misinterpretation of intended time for patient return. Thus, the aim of this study was to evaluate the comprehension of the current recall lay letter statement.MethodsThe Flesch-Kincaid grade level was used to assess readability of the lay letter currently used at the authors’ institution. A revised statement was formulated. A single paper-based survey presented both current and revised statements and asked questions to probe patients’ understanding of expected time to return. Surveys were provided to screening mammography patients at four outpatient imaging centers.ResultsThe Flesch-Kincaid grade levels of the current and revised statements were 12th and 4th grades, respectively. Five hundred ninety-nine surveys were analyzed. Survey data demonstrated that only 49.6% of all patients understood that the current statement requests return within 1 month specifically with the breast center, compared with 95.2% of patients with the revised statement (P < .001). Of the patients who misunderstood when to follow up with the breast center, about 80% had achieved less than a college degree (P < .001).ConclusionsThe grade level of the authors’ institution’s current lay letter statement is greater than the national recommendation for the average patient, which is between 6th and 8th grade. These data suggest that revising the language of recall statements to the recommended grade level would potentially improve patient understanding and compliance.     

Autologous fat grafting and breast cancer recurrences: Retrospective analysis of a series of 100 procedures in 64 patients

Abstract

Autologous fat transfer (AFT) enhances the cosmetic results of breast reconstruction and corrects breast conserving operation sequelae. The question of its oncological safety remains, as in-vitro experiences have shown that adipocytes can stimulate cancer cell proliferation. This study analysed the records of patients who had AFT after breast cancer from 2004–2009. The primary end-point was cancer recurrence. The secondary end-points were AFT complications and post-AFT mammogram modifications. Sixty-four patients (100 AFT) were included. The mean follow-up for AFT was 46.44 months (SD = 21.4). Two breast cancer recurrences were recorded (3.1%). Among 55 mammograms analysed, only one patient presented radiological abnormalities. One complication of AFT (donor-site infection) was recorded. This series is in favour of the oncological safety of AFT after breast cancer. An accurate evaluation of the recurrence risk, before performing AFT, is an essential prerequisite and must lead one to postpone or avoid this procedure in high-risk patients.     

Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature

Scintimammography is a relatively new, non-invasive diagnostic modality in the evaluation of breast cancer. The purpose of the current study was to review the existing literature on the accuracy of scintimammography in the diagnosis of breast cancer. A search of all articles published between 1st January 1967 and 31st December 1999 was conducted. A total of 64 unique studies were selected. Each scientific paper was reviewed for scientific merit by an epidemiologist, a surgeon and a surgical resident. Assessment of scientific merit was based on a scoring scheme developed for the study. The articles included in this review reported data on a total of 5340 patients assessed for breast cancer with scintimammography. The aggregated summary estimates on these patients were sensitivity: 85.2% and specificity: 86.6%. For patients with a palpable mass the sensitivity and specificity were 87.8 and 87.5%, respectively. For patients without a palpable mass the sensitivity was 66.8% and that for specificity was 86.9%. The results of this review have shown that scintimammography may be used effectively as an adjunct to mammography and physical examination in the diagnosis of breast cancer.     

In support of the Choosing Wisely campaign: Perceived higher risk leads to unnecessary imaging in accelerated partial breast irradiation?

Accelerated partial breast irradiation (APBI) is an increasingly utilized modality for early stage breast cancer as part of breast conservation therapy (BCT). There remains concern regarding local recurrence, requiring more frequent post‐radiation surveillance imaging. The purpose of this study is to determine clinical significance of frequent surveillance in this perceived higher risk population. Patients treated at a community academic medical center from 2005 to 2013 with partial breast radiation were retrospectively identified. All patients were treated with lumpectomy followed by balloon based APBI. Diagnostic, clinical, radiographic, and outcomes data were collected. One hundred and sixty‐nine patients were identified. Median age at time of diagnosis was 63. Stage was 0, I, and II in 27%, 64%, and 9%, respectively. Most patients had pure invasive ductal cancer. Ninety‐two percent and 99% of patients had imaging performed by 6 and 12 months (± 3 months) respectively. Median interval between end of radiation and first image, and subsequent 3 images were 6, 6, 9, and 12 months, respectively. Median follow‐up was 49 months for all patients (range 7‐106). Six patients experienced local recurrence: 4 invasive, all clinically detected, and none within the first 2 years. One patient had mammographically detected recurrent ductal carcinoma in situ. No mammographic images within the first year lead to diagnosis of recurrent cancer. APBI via balloon base brachytherapy offered women excellent locoregional control rates. Frequent mammographic surveillance did not result in increased detection of early recurrent disease. The result of our study are in line with the Choosing Wisely campaign recommendations to perform no more than annual follow‐up for women who have completed radiation as part of BCT, with first imaging done at 6‐12 months. We recommend mammographic surveillance be performed no more frequently than annually, with first image after BCT to be done 12 months from completion of radiation.